使用Player FM应用程序离线!
From the helm: Cyclopharm's (ASX:CYC) MD & CEO, James McBrayer
Manage episode 284144805 series 2611018
In this instalment of our From the helm series, Bell Direct’s Jessica Amir speaks to Cyclopharm's (ASX:CYC) MD & CEO, James McBrayer.
Cyclopharm is a little known Aussie company. Its medical technology is used in 60 countries around the world to help doctors identify lung capacity, as well as find potential blood clots. With earnings mostly coming from Europe, CYC's US journey gathers momentum with USFDA approval looming. The US is home to the world's largest nuclear medicine market.
In this video James discusses:
- (0:31) What CYC does & its "imminent" entry into the US
- (1:11) Key catalysts to drive share price growth
- (1:47) Commercialising the product in the US
- (2:46) CYC's product being endorsed to help fight COVID-19 in the US
- (3:31) How the company has reduced its risks
- (4:56) After a 110% rise in share price last year, what can investors expect for the year ahead?
57集单集
Manage episode 284144805 series 2611018
In this instalment of our From the helm series, Bell Direct’s Jessica Amir speaks to Cyclopharm's (ASX:CYC) MD & CEO, James McBrayer.
Cyclopharm is a little known Aussie company. Its medical technology is used in 60 countries around the world to help doctors identify lung capacity, as well as find potential blood clots. With earnings mostly coming from Europe, CYC's US journey gathers momentum with USFDA approval looming. The US is home to the world's largest nuclear medicine market.
In this video James discusses:
- (0:31) What CYC does & its "imminent" entry into the US
- (1:11) Key catalysts to drive share price growth
- (1:47) Commercialising the product in the US
- (2:46) CYC's product being endorsed to help fight COVID-19 in the US
- (3:31) How the company has reduced its risks
- (4:56) After a 110% rise in share price last year, what can investors expect for the year ahead?
57集单集
Tất cả các tập
×欢迎使用Player FM
Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。